Precision Medicine Stocks List

Recent Signals

Date Stock Signal Type
2021-02-26 AYLA 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-26 AYLA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-26 AYLA Narrow Range Bar Range Contraction
2021-02-26 CRSP Lower Bollinger Band Walk Weakness
2021-02-26 CRSP Stochastic Reached Oversold Weakness
2021-02-26 FUSN Doji - Bullish? Reversal
2021-02-26 FUSN Hammer Candlestick Bullish
2021-02-26 FUSN Fell Below 20 DMA Bearish
2021-02-26 FUSN Lizard Bullish Bullish Day Trade Setup
2021-02-26 GH Fell Below 50 DMA Bearish
2021-02-26 GMTX New 52 Week Closing High Bullish
2021-02-26 IDYA 180 Bullish Setup Bullish Swing Setup
2021-02-26 IDYA Pocket Pivot Bullish Swing Setup
2021-02-26 IDYA Crossed Above 20 DMA Bullish
2021-02-26 INMB Lower Bollinger Band Walk Weakness
2021-02-26 KDNY Stochastic Reached Overbought Strength
2021-02-26 NTLA Pocket Pivot Bullish Swing Setup
2021-02-26 NTLA Stochastic Reached Oversold Weakness
2021-02-26 NTLA Lower Bollinger Band Walk Weakness
2021-02-26 ORIC Fell Below 50 DMA Bearish
2021-02-26 ORIC Fell Below 20 DMA Bearish
2021-02-26 PRAX Stochastic Reached Oversold Weakness
2021-02-26 PRAX Lower Bollinger Band Walk Weakness
2021-02-26 PROG Narrow Range Bar Range Contraction
2021-02-26 PROG NR7 Range Contraction
2021-02-26 RPTX Spinning Top Other
2021-02-26 STOK Pocket Pivot Bullish Swing Setup

Recent News for Precision Medicine Stocks

Date Stock Title
Feb 27 INMB The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Feb 27 NTLA 15 Fastest Growing Biotech Companies in the US
Feb 27 RLAY Relay Therapeutics: A Long-Term Position In Data-Driven Drug Developer Looks Attractive
Feb 26 STOK Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 26 NTLA Intellia (NTLA) Miss Earnings & Revenues Estimates in Q4
Feb 26 NTLA Intellia Therapeutics, Inc. (NTLA) Q4 2020 Earnings Call Transcript
Feb 25 NTLA Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q4 2020 Results - Earnings Call Transcript
Feb 25 GH Why Guardant Health Stock Is Sinking Today
Feb 25 INMB INmune Bio, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results and Provide a Corporate Update on Thursday, March 4
Feb 25 NTLA Intellia Therapeutics EPS misses by $0.09, misses on revenue
Feb 25 NTLA Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results
Feb 25 GH What's Behind Guardant Health's Disappointing Q4 Results
Feb 25 GH Guardant Health, Inc. (GH) CEO Helmy Eltoukhy on Q4 2020 Results - Earnings Call Transcript
Feb 25 GH Guardant Health Inc (GH) Q4 2020 Earnings Call Transcript
Feb 24 GH Guardant Health: Q4 Earnings Insights
Feb 24 GH Guardant Health EPS misses by $0.35, beats on revenue
Feb 24 GH Guardant Health Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Revenue Outlook for Full Year 2021
Feb 24 POAI Predictive Oncology: Potentially Undervalued Drug Discovery AI Company
Feb 24 NTLA Intellia Therapeutics Q4 2020 Earnings Preview
Feb 24 POAI POAI ‘s Helomics Division Announces Progress on Milestones for its AI-Driven Model of Ovarian Cancer

Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient, instead of a one‐drug‐fits‐all model. In precision medicine, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics.

More about Precision Medicine
Browse All Tags